You get provider consultations, dosing guidance, and medication delivered to your door
The time point for injections was also selected before NTG administration
Remember, weight loss is a personal journey, and what works for one person may not work for another
Certification ensures that Semaglutide is produced consistently and safely, providing confidence to healthcare providers and patients
Fabriqu dans notre laboratoire en France, selon les Bonnes Pratiques de Fabrication (BPF) en vigueur
1 ,2 About the REDEFINE 1 trial REDEFINE 1 was a double-blind, placebo-and active-controlled 68-week efficacy and safety phase 3 trial of once-weekly CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg), cagrilintide 2.4 mg monotherapy and semaglutide 2.4 mg monotherapy versus placebo in 3,417 adults with obesity (BMI 30 kg/m 2 ), or overweight (BMI 27 kg/m 2 ) with one or more obesity-related comorbidities, and without type 2 diabetes